Clinical Trial Update: Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs)

View source ↗

Summary

A completed clinical trial evaluated Kaletra's impact on resistance to antiretrovirals in people with HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: Abbott | Conditions: HIV Infection | Status: COMPLETED